Consorzio Interuniversitario Nazionale per la Bio-Oncologia www.cinbo.org
DIRECTOR Clara Natoli SCIENTIFIC SECRETARIAT
Consiglia Carella Michele De Tursi Antonino Grassadonia
Nicola Tinari
SCIENTIFIC ADVISORY BOARD Vincenzo Adamo
Barbara Barboni Roberto Bianco Giovanni Brandi Marco Carini Leonardo Della Salda
Corrado Ficorella Francesco Grignani
Lorenzo Lo Muzio Patrizia Querzoli
Antonio Russo Marina Scarpelli
Silverio Tomao Giuseppe Tonini ORGANIZING SECRETARIAT
Giovanna Di Credico OFFICES
Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO) c/o Sezione di Oncologia Medica Università G. D’Annunzio - Via dei Vestini, 31
66100 Chieti - Italy Phone: +39 0871 3556732
Fax +39 0871 3556707 [email protected] PROVIDER ECM ID. 50
Strategie S.r.L. - Via Piave 110/7 - Pescara Phone: 085 74143 - Fax: 085 378220
[email protected] www.strategieonweb.it
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
presents
BREAKTHROUGHS IN GASTROINTESTINAL CANCER
TREATMENT
October 19, 2017
Aula MULTIMEDIALE c/o Rettorato
Università degli Studi “G. D’Annunzio”
Via dei Vestini, 31 Chieti
Directors
Stefano Cascinu & Clara Natoli
CINBO
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
Evento n. ECM 50-201136 per Medici Chirurghi specialisti in:
ALLERGOLOGIA ED IMMUNOLOGIA CLINICA; EMATOLOGIA;
ENDOCRINOLOGIA; GASTROENTEROLOGIA; GENETICA MEDICA;
MALATTIE DELL’APPARATO RESPIRATORIO; RADIOTERAPIA;
CHIRURGIA GENERALE; CHIRURGIA PLASTICA E RICOSTRUTTIVA;
CHIRURGIA TORACICA; GINECOLOGIA E OSTETRICIA; ANATOMIA PATOLOGICA; FARMACOLOGIA E TOSSICOLOGIA CLINICA;
MEDICINA NUCLEARE; RADIODIAGNOSTICA; IGIENE, EPIDEMIOLOGIA E SANITÀ PUBBLICA.;
per Farmacisti (Farmacia Ospedaliera); per Biologi Crediti ECM: 6
si ringrazia per il contributo incondizionato:
La partecipazione è gratuita.
Le iscrizioni si accettano on line sul sito del Provider www.strategieonweb.it - pagina ECM 2017
Con il patrocino di:
Stampa Demagraf - Pescara
9.30 Registration & Welcome coffee 10.10 Opening
Session I - Colorectal cancer
Moderators: Carlo Garufi & Corrado Ficorella
10.20 Short or long adjuvant treatment: can we use new trials to decide it? Roberto Labianca 10.40 Metastatic colorectal cancer, right vs left:
how to take into consideration it in the clinical practice? Alberto Zaniboni
11.00 Immunotherapy and new perspectives. Fabio Gelsomino
11.20 To resect the unresectable? Liver metastases responding to treatment. Sara Lonardi 11.40 Discussion leaders: Sara Lonardi & Raffaella Basilico
Coffee break
Session II - Gastric cancer
Moderators: Lucio Laudadio & Amedeo Pancotti
12.20 Perioperative treatment: ECX, CF, FLOT just an option? Ferdinando De Vita 12.40 The continuum of care in advanced gastric cancer: myth o reality? Mario Scartozzi
13.00 Ready to use the molecular classifi cation? Riccardo Giampieri
Discussion leaders: Mario Scartozzi & Daniele Santini
Light lunch
Session III - Pancreatic cancer
Moderators: Nicola Tinari & Cosima Chiapperino
14.40 Adjuvant therapy: what to do waiting for new trials. Enrico Vasile 15.00 Locally advanced unresectable disease: treatment options. Kalliopi Andrikou 15.20 First and second line chemotherapy: a betters sequence? Nicola Silvestris
Discussion leaders: Nicola Silvestris & Domenico Genovesi
Coffee break
Session IV - Neuroendocrine tumors
Moderators: Donato Natale & Nicola D’Ostilio
16.20 Ki67 and treatment choice in fi rst and second line. Nicola Fazio
16.40 Chemotherapy an old, new tool. Toni Ibrahim
17.00 Radiometabolic treatment: is there any room? Gianluigi Martino Discussion leaders: Maria Teresa Martino & Domenico Angelucci
Conclusions
Program Faculty
Kalliopi Andrikou [email protected] Modena
Domenico Angelucci [email protected] Chieti
Raffella Basilico [email protected] Chieti
Cosima Chiapperino [email protected] Chieti
Ferdinando De Vita
[email protected] Napoli
Nicola D’Ostilio
[email protected] Lanciano (CH)
Nicola Fazio [email protected] Milano
Corrado Ficorella corrado.fi [email protected] L’Aquila
Carlo Garufi carlo.garufi @ausl.pe.it Pescara
Fabio Gelsomino
[email protected] Modena
Domenico Genovesi [email protected] Chieti
Riccardo Giampieri [email protected] Ancona
Toni Ibrahim [email protected] Meldola (FC) Roberto Labianca [email protected] Bergamo
Lucio Laudadio
[email protected] Lanciano (CH)
Sara Lonardi
[email protected] Padova
Gianluigi Martino
[email protected] Chieti
MariaTeresa Martino [email protected] Chieti
Donato Natale
[email protected] Pescara
Clara Natoli [email protected] Chieti
Amedeo Pancotti [email protected] Teramo
Daniele Santini [email protected] Roma
Mario Scartozzi
[email protected] Monserrato (CA) Nicola Silvestris
[email protected] Bari
Nicola Tinari [email protected] Chieti Enrico Vasile [email protected] Pisa
Alberto Zaniboni [email protected] Brescia
11.20 To resect the unresectable? Liver metastases responding to treatment. Sara Lonardi
11.00 Immunotherapy and new perspectives. Fabio Gelsomino
10.20 Short or long adjuvant treatment: can we use new trials to decide it? Roberto Labianca how to take into consideration it in the clinical practice? Alberto Zaniboni
13.00 Ready to use the molecular classifi cation? Riccardo Giampieri
12.40 The continuum of care in advanced gastric cancer: myth o reality? Mario Scartozzi 12.20 Perioperative treatment: ECX, CF, FLOT just an option? Ferdinando De Vita
15.20 First and second line chemotherapy: a betters sequence? Nicola Silvestris 15.00 Locally advanced unresectable disease: treatment options. Kalliopi Andrikou 14.40 Adjuvant therapy: what to do waiting for new trials. Enrico Vasile
17.00 Radiometabolic treatment: is there any room? Gianluigi Martino
16.40 Chemotherapy an old, new tool. Toni Ibrahim
16.20 Ki67 and treatment choice in fi rst and second line. Nicola Fazio 9.30 Registration & Welcome coffee
10.10 Opening
10.20 Short or long adjuvant treatment: can we use new trials to decide it? Roberto Labianca 10.40 Metastatic colorectal cancer, right vs left:
11.00 Immunotherapy and new perspectives. Fabio Gelsomino
11.20 To resect the unresectable? Liver metastases responding to treatment. Sara Lonardi 11.20 To resect the unresectable? Liver metastases responding to treatment. Sara Lonardi 11.40
12.00
12.20 Perioperative treatment: ECX, CF, FLOT just an option? Ferdinando De Vita 12.40 The continuum of care in advanced gastric cancer: myth o reality? Mario Scartozzi
13.00 Ready to use the molecular classifi cation? Riccardo Giampieri
13.20 13.40
14.40 Adjuvant therapy: what to do waiting for new trials. Enrico Vasile 15.00 Locally advanced unresectable disease: treatment options. Kalliopi Andrikou
16.20 Ki67 and treatment choice in fi rst and second line. Nicola Fazio 15.20 First and second line chemotherapy: a betters sequence? Nicola Silvestris 15.40
16.00
16.40 Chemotherapy an old, new tool. Toni Ibrahim
17.00 Radiometabolic treatment: is there any room? Gianluigi Martino 17.20
17.40
